US regulators approve Roche’s new and faster COVID-19 test
Swiss pharmaceutical giant Roche announced it had received emergency approval from US regulators for a new and much faster test for diagnosing the deadly new...
Continue ReadingNo shortage of APIs and formulations in the country: Govt
The National Pharmaceutical Pricing Authority (NPPA) has been assured by pharma industry body IDMA that there is no shortage of active pharmaceutical ingredients and formulations...
Continue ReadingHuman trials for a coronavirus vaccine could begin ‘within a few weeks,’ top US health official says
Human trials for a potential vaccine to prevent COVID-19 could begin “within a few weeks” with a vaccine ready for public use within the next...
Continue ReadingHyderabad scientist finds two compounds to fight coronavirus
These proteins were found to bind with two separate compounds, Aza-Peptide Epoxide (APE) and GRL0617, that inhibited the ability of the virus to replicate, impairing...
Continue ReadingCentral govt to launch iVEDA portal for tracking drugs meant for export soon
The central government will soon launch Integrated Validation of Exports of Drugs from India and its Authentication (iVEDA) portal for drug authentication and tracking and...
Continue ReadingWorkshop on Regulatory Issues in Healthcare: Recent Developments Seminar hall, School of Life Sciences, University of Hyderabad 21st March, 2020, 09.00 to 18.00 hrs
About the workshop: Hyderabad is home to many pharmaceutical companies that excel in manufacturing of generic drugs. It is fast emerging as major Biologics hub...
Continue ReadingTeva launches State’s first inhaler recycling programme
Scheme could remove roughly 4.4m devices currently incinerated or sent to landfill Pharmaceuticals giant Teva launched the State’s first inhaler recycling project in a move...
Continue ReadingState lethargy amidst cough syrup poisoning
A national recall of Coldbest-PC, the medicine behind the death of 12 children in Jammu, is needed A few days ago, we learnt that 12...
Continue ReadingLaurus Labs banking on vertical integration to crack anti-HIV tenders and US formulations mkts
The company has so far filed 24 abbreviated new drug applications (ANDAs) with US FDA. It has five final approvals, three tentative approvals and two...
Continue Reading